Enhanced strategic consultation and new products like Medicare Predictive Model and Enrollment Capabilities are changing Prime’s government programs and delivering better access and costs to members

The content in this publication is not a substitute for professional medical advice. For questions regarding any medical condition or if you need medical advice, please contact your health care...

Prime leaders joined peers from Free Market Health and EmblemHealth at Asembia’s AXS26 conference to share how specialty care needs more visibility, more configurability and practical innovation

A Q&A with Kristen Tveit, SVP, chief financial officer, Magellan Rx

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

AMCP Nexus offers opportunity to nurture next generation of managed care leaders

Live updates from AMCP Annual Meeting

Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...

Configure the table properties Dosage and administration In the Phase 3 VALOR clinical trial, brepocitinib was administered orally once daily at a dose of 15 mg or 30 mg for 52 weeks. Place in...

cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care  Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...

denecimig (Mim8) - Hematologic The Deep dive section features an analysis for select pipeline drugs that are expected to be FDA-approved in the upcoming quarters. Selected agents are expected to...

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of...

Event features Caitlin Berry, senior principal of public policy and government affairs at Prime Therapeutics

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

Recent research presented at AMCP 2026 shows treatment location affects cost and use. Here’s how Prime is poised to support patients.

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Nathan Downhour, senior vice president of strategic pharmacy solutions, led the implementation of Prime’s innovative Advocate+ care model